Advertisement
UK markets close in 6 hours 50 minutes

  • FTSE 100

    8,237.36
    -16.82 (-0.20%)
     

  • FTSE 250

    20,645.85
    -59.42 (-0.29%)
     

  • AIM

    806.15
    -2.21 (-0.27%)
     

  • GBP/EUR

    1.1778
    +0.0029 (+0.25%)
     

  • GBP/USD

    1.2762
    -0.0002 (-0.01%)
     

  • Bitcoin GBP

    53,112.67
    -132.20 (-0.25%)
     

  • CMC Crypto 200

    1,458.87
    -25.83 (-1.74%)
     

  • S&P 500

    5,306.04
    +1.32 (+0.02%)
     

  • DOW

    38,852.86
    -216.74 (-0.55%)
     

  • CRUDE OIL

    80.41
    +0.58 (+0.73%)
     

  • GOLD FUTURES

    2,347.70
    -8.80 (-0.37%)
     

  • NIKKEI 225

    38,556.87
    -298.50 (-0.77%)
     

  • HANG SENG

    18,477.01
    -344.15 (-1.83%)
     

  • DAX

    18,598.41
    -79.46 (-0.43%)
     

  • CAC 40

    8,002.09
    -55.71 (-0.69%)
     
Money:

What's best?

Should you support your children at university or help them on to property ladder?

Are You Looking for a Top Momentum Pick? Why TransMedics (TMDX) is a Great Choice

Zacks Equity Research
·4-min read

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.

Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.

Below, we take a look at TransMedics (TMDX), which currently has a Momentum Style Score of A. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate revisions.

It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. TransMedics currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period.

ADVERTISEMENT

You can see the current list of Zacks #1 Rank Stocks here >>>

Set to Beat the Market?

Let's discuss some of the components of the Momentum Style Score for TMDX that show why this medical technology company shows promise as a solid momentum pick.

A good momentum benchmark for a stock is to look at its short-term price activity, as this can reflect both current interest and if buyers or sellers currently have the upper hand. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area.

For TMDX, shares are up 1.55% over the past week while the Zacks Medical - Instruments industry is down 0.56% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 41.94% compares favorably with the industry's 1.69% performance as well.

While any stock can see its price increase, it takes a real winner to consistently beat the market. That is why looking at longer term price metrics -- such as performance over the past three months or year -- can be useful as well. Over the past quarter, shares of TransMedics have risen 49.46%, and are up 76.92% in the last year. In comparison, the S&P 500 has only moved 5.3% and 28.9%, respectively.

Investors should also pay attention to TMDX's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. TMDX is currently averaging 1,112,849 shares for the last 20 days.

Earnings Outlook

The Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with TMDX.

Over the past two months, 5 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost TMDX's consensus estimate, increasing from -$0.22 to $0.76 in the past 60 days. Looking at the next fiscal year, 4 estimates have moved upwards while there have been 1 downward revision in the same time period.

Bottom Line

Given these factors, it shouldn't be surprising that TMDX is a #2 (Buy) stock and boasts a Momentum Score of A. If you're looking for a fresh pick that's set to soar in the near-term, make sure to keep TransMedics on your short list.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

TransMedics Group, Inc. (TMDX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research